Company: HROW
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001641172-25-009263
Chunk: 11

Company: HARROW, INC.
Filing Date: 2025-05-08
Form: 10-Q
Item: Item 1
Chunk 11
---
 yield analysis
and any adjustments to implied yield associated with the Company’s fundamental measures.

The following table presents the estimated fair
values and the carrying values: 

 SCHEDULE
OF ESTIMATED FAIR VALUE

    March 31, 2025

    December 31, 2024

    Carrying Value

    Fair Value

    Carrying Value

    Fair Value

    2026 Notes
     
    $
     74,195,000

    $
    76,080,000

    $
    74,002,000

    $
    75,840,000

    2027 Notes
     
    $
     36,306,000

    $
     43,068,000

    $
    38,130,000

    $
    42,198 ,000

    Oaktree Loan
     
    $
     108,313,000

    $
    113,210,000

    $
    107,407,000

    $
    112,932,000

The Company’s other financial instruments
include cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, accrued payroll and related liabilities,
deferred revenue and customer deposits and operating lease liabilities. The carrying amount of these financial instruments, except for
operating lease liabilities, approximates fair value due to the short-term maturities of these instruments. Based on borrowing rates currently
available to the Company, the carrying value of the operating lease liabilities approximate their respective fair values.

Basic and Diluted Net Loss per Common Share

Basic net loss per common share is computed by
dividing net loss attributable to common stockholders for the period by the weighted average number of common shares outstanding during
the period. Diluted net loss per share is computed by dividing the net loss attributable to common stockholders for the period by the
weighted average number of common and common equivalent shares, such as stock options, restricted stock units (“RSUs”), performance
stock units (“PSUs”), and warrants, outstanding during the period. Common equivalent shares (using the treasury stock method)
from stock options, unvested RSUs, unvested PSUs and warrants were 4,367,766 and 4,318,057 at March 31, 2025 and 2024, respectively, and
are excluded in the calculation of diluted net loss per common share for the periods presented, because the effect is anti-dilutive